Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
38.00
-2.33 (-5.78%)
Mar 31, 2025, 11:00 AM EDT - Market open
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $231.74 million as of March 31, 2025. Its market cap has increased by 1,972.64% in one year.
Market Cap
231.74M
Enterprise Value
226.33M
1-Year Change
1,972.64%
Ranking
Category
Stock Price
$38.00
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $231.74M, a decrease of -16.08%. That is a compound annual growth rate of -3.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.36B |
| UnitedHealth Group | 479.26B |
| Johnson & Johnson | 400.85B |
| AbbVie | 370.84B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 229.14B |
| Merck & Co. | 225.30B |